BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 17803560)

  • 1. Surgical volume influences survival in patients undergoing resections for stage II colon cancers.
    Morris M; Platell CF
    ANZ J Surg; 2007 Oct; 77(10):902-6. PubMed ID: 17803560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival and time interval from surgery to start of chemotherapy among colon cancer patients.
    Zeig-Owens R; Gershman ST; Knowlton R; Jacobson JS
    J Registry Manag; 2009; 36(2):30-41; quiz 61-2. PubMed ID: 19694115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of patients with high-risk stage II colon cancer for adjuvant therapy.
    Quah HM; Chou JF; Gonen M; Shia J; Schrag D; Landmann RG; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
    Dis Colon Rectum; 2008 May; 51(5):503-7. PubMed ID: 18322753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staging error does not explain the relationship between the number of lymph nodes in a colon cancer specimen and survival.
    Moore J; Hyman N; Callas P; Littenberg B
    Surgery; 2010 Mar; 147(3):358-65. PubMed ID: 19962166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of spontaneous tumour perforation on outcome following colon cancer surgery.
    Abdelrazeq AS; Scott N; Thorn C; Verbeke CS; Ambrose NS; Botterill ID; Jayne DG
    Colorectal Dis; 2008 Oct; 10(8):775-80. PubMed ID: 18266887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
    Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
    Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should total number of lymph nodes be used as a quality of care measure for stage III colon cancer?
    Wang J; Kulaylat M; Rockette H; Hassett J; Rajput A; Dunn KB; Dayton M
    Ann Surg; 2009 Apr; 249(4):559-63. PubMed ID: 19300237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population-based study of prognostic factors in stage II colonic cancer.
    Morris M; Platell C; de Boer B; McCaul K; Iacopetta B
    Br J Surg; 2006 Jul; 93(7):866-71. PubMed ID: 16622901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer.
    Hershman D; Hall MJ; Wang X; Jacobson JS; McBride R; Grann VR; Neugut AI
    Cancer; 2006 Dec; 107(11):2581-8. PubMed ID: 17078055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study of outcomes of emergency and elective surgeries for complicated colonic cancer.
    Biondo S; Martí-Ragué J; Kreisler E; Parés D; Martín A; Navarro M; Pareja L; Jaurrieta E
    Am J Surg; 2005 Apr; 189(4):377-83. PubMed ID: 15820446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colon cancer and low lymph node count: who is to blame?
    Jakub JW; Russell G; Tillman CL; Lariscy C
    Arch Surg; 2009 Dec; 144(12):1115-20. PubMed ID: 20026828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymph node ratio: role in the staging of node-positive colon cancer.
    Wang J; Hassett JM; Dayton MT; Kulaylat MN
    Ann Surg Oncol; 2008 Jun; 15(6):1600-8. PubMed ID: 18327530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-tumoral vascular or perineural invasion as prognostic factors for long-term survival in early stage non-small cell lung carcinoma.
    Poncelet AJ; Cornet J; Coulon C; Collard P; Noirhomme P; Weynand B;
    Eur J Cardiothorac Surg; 2008 May; 33(5):799-804. PubMed ID: 18374590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor budding as an index to identify high-risk patients with stage II colon cancer.
    Nakamura T; Mitomi H; Kanazawa H; Ohkura Y; Watanabe M
    Dis Colon Rectum; 2008 May; 51(5):568-72. PubMed ID: 18286339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Young age influences treatment but not outcome of colon cancer.
    Quah HM; Joseph R; Schrag D; Shia J; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
    Ann Surg Oncol; 2007 Oct; 14(10):2759-65. PubMed ID: 17593332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved survival in young women with colorectal cancer.
    Koo JH; Jalaludin B; Wong SK; Kneebone A; Connor SJ; Leong RW
    Am J Gastroenterol; 2008 Jun; 103(6):1488-95. PubMed ID: 18510616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant chemotherapy for stage C colonic cancer in a multidisciplinary setting.
    Chapuis PH; Bokey EL; Clarke S; Beale P; Dent OF
    ANZ J Surg; 2009 Oct; 79(10):685-92. PubMed ID: 19878161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgeon volume compared to hospital volume as a predictor of outcome following primary colon cancer resection.
    Schrag D; Panageas KS; Riedel E; Hsieh L; Bach PB; Guillem JG; Begg CB
    J Surg Oncol; 2003 Jun; 83(2):68-78; discussion 78-9. PubMed ID: 12772198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical staging of nasopharyngeal carcinoma based on MRI: suggestions for improving the Chinese '92 staging system].
    Mao YP; Hong MH; Sun Y; Liang SB; Li L; Liu LZ; Tang LL; Cao SM; Lin AH; Lu TX; Liu MZ; Ma J
    Ai Zheng; 2007 Oct; 26(10):1099-106. PubMed ID: 17927881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumour location is a prognostic factor for survival in colonic cancer patients.
    Sjo OH; Lunde OC; Nygaard K; Sandvik L; Nesbakken A
    Colorectal Dis; 2008 Jan; 10(1):33-40. PubMed ID: 17672872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.